L9 BIOSCIENCE: WHAT WE DO
•L9 BioScience is a technology that increases the bioavailability of all Active Pharmaceutical Ingredients (API’s)
•9-fold to 18-fold increase in API bioavailability
•The L9 process improves clinical outcomes, reduces toxicity and reduces cost
•Up to 50% API retention without bioaccumulation
•The L9 process is patented, with 16 more discreet claims in the patent landscape
INCREASED BIOAVAILABILITY: WHAT DOES THIS MEAN?
RESURRECTING FAILED PROSPECTS